Efficacy of Moderna's Next-Gen COVID-19 Vaccine Confirmed in Trial - Monthly Prescribing Reference

A phase 3 trial evaluating Moderna’s next-generation COVID-19 vaccine, mRNA-1283, met its primary vaccine efficacy endpoint.
The phase 3 NextCOVE study (ClinicalTrials.gov Identifier: NCT05815498) c… [+1408 chars]